Toxicology – Ventricular Dysrhythmias

Core Concept

Toxicologic ventricular dysrhythmias are abnormal rhythms or conduction disturbances involving the ventricles that result from exposure to a drug, chemical, or toxin.

They range from:

• Premature ventricular complexes
• Wide-complex tachycardia
• Monomorphic or polymorphic ventricular tachycardia
• Torsades de pointes
• Ventricular fibrillation
• Severe intraventricular conduction delay

In poisoning, treatment should address both the rhythm and the toxicologic mechanism producing it.

Major Mechanisms

Toxins can provoke ventricular dysrhythmias through several pathways.

1. Sodium-Channel Blockade

Fast sodium-channel inhibition slows ventricular depolarization.

This produces:

Slowed conduction → QRS widening → ventricular dysrhythmia

Important causes include:

• Tricyclic antidepressants
• Certain first-generation antihistamines
• Class I antiarrhythmics
• Carbamazepine in severe poisoning
• Some antipsychotics
• Other membrane-stabilizing drugs

Severe sodium-channel blockade may also cause:

• Hypotension
• Seizures
• Coma

2. Potassium-Channel Effects and QT Prolongation

Delayed ventricular repolarization can prolong the QT interval.

Excessive QT prolongation increases susceptibility to torsades de pointes, a polymorphic ventricular tachycardia.

Risk is increased by:

• Hypokalemia
• Hypomagnesemia
• Bradycardia
• Multiple QT-prolonging drugs
• Congenital long-QT syndromes

3. Myocardial Ischemia

Toxicant-associated myocardial ischemia may result from:

• Coronary vasospasm
• Severe hypertension
• Hypotension
• Increased myocardial oxygen demand
• Reduced oxygen delivery

Cocaine and other sympathomimetics are important examples.

Ischemic myocardium is electrically unstable and may develop ventricular dysrhythmias.

4. Hypoxia and Impaired Oxygen Delivery

Ventricular dysrhythmias may occur secondary to:

• Severe hypoventilation
• Pulmonary injury
• Carbon monoxide poisoning
• Methemoglobinemia
• Cyanide toxicity
• Profound shock

Correcting oxygenation and ventilation is therefore part of dysrhythmia management.

5. Electrolyte Disturbances

Important abnormalities include:

• Hyperkalemia
• Hypokalemia
• Hypomagnesemia
• Hypocalcemia

These may directly alter cardiac conduction or increase susceptibility to drug-induced dysrhythmias.

6. Direct Cardiac Toxicity

Certain poisons directly disturb:

• Automaticity
• AV conduction
• Myocardial contractility
• Intracellular calcium handling
• Ion-channel function

Examples include:

• Digoxin
• Beta-blockers
• Calcium channel blockers
• Chloroquine/hydroxychloroquine
• Certain antiarrhythmics

Risk Factors

Severe ventricular dysrhythmias are more likely in patients with:

• Pre-existing structural heart disease
• Coronary artery disease
• Baseline conduction abnormalities
• Congenital long-QT syndrome
• Electrolyte disturbances
• Hypoxia
• Severe acidemia
• Large or mixed overdose
• Multiple QT-prolonging medications

Important Toxicologic Causes

Tricyclic Antidepressants

TCAs produce cardiotoxicity primarily through fast sodium-channel blockade, with additional autonomic and myocardial effects.

Typical findings include:

• Sinus tachycardia
• QRS widening
• Hypotension
• Altered mental status
• Seizures
• Ventricular dysrhythmias

A terminal R wave in lead aVR may support sodium-channel blockade, but it is not specific for TCA poisoning.

Increasing QRS duration generally indicates increasing sodium-channel toxicity.

Sodium bicarbonate is the key treatment for clinically significant TCA-associated sodium-channel blockade.

First-Generation Antihistamines

Certain antihistamines, particularly in severe overdose, can produce both:

• Anticholinergic toxicity
• Sodium-channel blockade

Possible findings include:

• Tachycardia
• Mydriasis
• Dry skin and mucosa
• Delirium
• Seizures
• QRS widening
• QT prolongation
• Ventricular dysrhythmias

Diphenhydramine is an important example.

Class I Antiarrhythmics

These medications can paradoxically produce serious dysrhythmias in overdose.

Depending on the specific agent, effects may include:

• QRS widening
• QT prolongation
• Hypotension
• Ventricular tachycardia
• Torsades de pointes

Adding another sodium-channel-blocking antiarrhythmic may worsen toxicity.

Cocaine and Other Sympathomimetics

Stimulants can produce ventricular dysrhythmias through:

• Catecholamine excess
• Increased myocardial oxygen demand
• Coronary vasoconstriction
• Hyperthermia
• Ischemia
• Acidosis

Cocaine additionally has sodium-channel-blocking properties.

Associated findings include:

• Agitation
• Tachycardia
• Hypertension
• Diaphoresis
• Mydriasis
• Hyperthermia
• Seizures
• Rhabdomyolysis

Theophylline

Theophylline toxicity can cause:

• Marked sinus tachycardia
• Supraventricular dysrhythmias
• Ventricular ectopy
• Ventricular dysrhythmias in severe poisoning

Associated clues include:

• Tremor
• Recurrent vomiting
• Hypokalemia
• Hyperglycemia
• Seizures

Severe theophylline poisoning may require extracorporeal removal.

Digoxin

Digoxin toxicity can produce an unusually broad range of dysrhythmias because it affects both:

• Automaticity
• AV nodal conduction

Possible rhythms include:

• Premature ventricular complexes
• AV block
• Junctional rhythms
• Atrial tachycardia with AV block
• Bidirectional ventricular tachycardia
• Ventricular tachycardia/fibrillation

Associated findings may include:

• Nausea/vomiting
• Confusion
• Visual abnormalities
• Bradycardia
• Hyperkalemia in significant acute poisoning

Bidirectional ventricular tachycardia is an important clue to digoxin toxicity, although it is not completely specific.

Clinically important digoxin toxicity is treated with digoxin immune Fab.

Chloroquine and Hydroxychloroquine

Severe poisoning can rapidly produce:

• Hypotension
• Hypokalemia
• QRS widening
• QT prolongation
• Ventricular dysrhythmias
• Cardiovascular collapse

The combination of profound hypotension, conduction abnormalities, and hypokalemia after a compatible exposure is particularly concerning.

Carbamazepine

Large overdoses may produce:

• CNS depression
• Ataxia
• Nystagmus
• Seizures
• QRS widening
• Ventricular dysrhythmias

Severe cardiotoxicity can resemble other sodium-channel-blocking poisonings.

Organophosphates and Carbamates

Cholinergic poisoning can produce variable cardiac effects.

Possible rhythms include:

• Sinus tachycardia
• Bradycardia
• AV conduction abnormalities
• Ventricular dysrhythmias

Associated findings include:

• Miosis
• Salivation
• Bronchorrhea
• Vomiting
• Diarrhea
• Sweating
• Fasciculations
• Weakness

Heart rate alone cannot reliably identify or exclude a cholinergic syndrome.

Thyroid Hormone

Excess thyroid hormone usually produces:

• Sinus tachycardia
• Supraventricular tachyarrhythmias
• Atrial fibrillation

Ventricular dysrhythmias are less common but may occur in severe thyrotoxicosis, particularly when underlying cardiac disease is present.

Nontoxicologic Differential Diagnosis

Always consider causes unrelated to poisoning, including:

• Acute coronary syndrome
• Myocarditis
• Structural heart disease
• Congenital arrhythmia syndromes
• Intracranial catastrophe
• Hypoglycemia
• Severe hypoxia
• Electrolyte abnormalities
• Acid-base disturbances

A toxic exposure and a primary cardiac disorder may coexist.

Clinical Presentation

Patients may report:

• Palpitations
• Chest discomfort
• Dyspnea
• Weakness
• Dizziness
• Lightheadedness
• Presyncope

Severe ventricular dysrhythmias can cause:

• Syncope
• Hypotension
• Seizure-like activity from cerebral hypoperfusion
• Cardiogenic shock
• Cardiac arrest

In a poisoning patient, sudden syncope should raise concern for a significant dysrhythmia.

Clinical Clues to the Cause

Wide QRS + Seizures + Hypotension

Strongly consider:

• TCA poisoning
• Other sodium-channel blockers

Wide QRS + Anticholinergic Findings

Consider:

• TCA
• Diphenhydramine or another cardiotoxic antihistamine
• Other antimuscarinic drugs with sodium-channel effects

Ventricular Dysrhythmia + Severe Agitation/Hyperthermia

Consider:

• Cocaine
• Amphetamines
• Other sympathomimetics

Dysrhythmia + Vomiting + Tremor + Hypokalemia

Consider:

Theophylline toxicity

Dysrhythmia + AV Block

Consider:

• Digoxin
• Beta-blockers
• Calcium channel blockers
• Other conduction-suppressing drugs

Dysrhythmia + Hyperkalemia

Consider:

• Significant acute digoxin toxicity
• Severe renal failure
• Potassium poisoning
• Severe acidosis/tissue injury

Hyperkalemia itself can produce progressive conduction abnormalities and malignant dysrhythmias.

Dysrhythmia + Hypokalemia

Consider:

• Theophylline
• β₂-agonists
• Chloroquine/hydroxychloroquine

Hypokalemia also increases susceptibility to QT-related dysrhythmias.

ECG Evaluation

Obtain a 12-lead ECG and institute continuous cardiac monitoring in clinically important toxicologic dysrhythmias.

Evaluate:

• Rhythm
• Rate
• PR interval
• QRS duration
• QT/QTc
• AV conduction
• Ventricular ectopy
• Ischemic changes

Serial ECGs are useful because conduction abnormalities can evolve as absorption and toxicity progress.

QRS Widening

A widened QRS in poisoning should prompt consideration of sodium-channel blockade.

Potential causes include:

• TCAs
• Certain antihistamines
• Class I antiarrhythmics
• Carbamazepine
• Cocaine
• Other sodium-channel blockers

Treatment should be based on the overall evidence of clinically important sodium-channel toxicity, rather than relying on one rigid QRS threshold.

QT Prolongation

QT prolongation indicates delayed ventricular repolarization and may predispose to torsades de pointes.

Assess for:

• QT-prolonging drugs
• Hypokalemia
• Hypomagnesemia
• Hypocalcemia
• Bradycardia

Serial ECG monitoring is important when QT prolongation is substantial or evolving.

Laboratory Evaluation

Useful investigations may include:

• Bedside glucose
• Sodium
• Potassium
• Calcium
• Magnesium
• Bicarbonate
• BUN/creatinine
• Blood gas when clinically indicated
• Lactate

Targeted toxicant concentrations may include:

• Digoxin
• Theophylline
• Salicylate
• Other measurable drugs when clinically relevant

Acetaminophen testing should be considered in significant intentional or unknown ingestions because early toxicity may be clinically silent.

Broad urine drug screening has limited ability to establish the cause of a dysrhythmia.

Initial Management

The first priorities are:

Airway → breathing → circulation → rhythm assessment → identify and reverse the toxicologic mechanism

Immediately address:

• Hypoxemia
• Inadequate ventilation
• Severe acid-base disturbance
• Electrolyte abnormalities
• Hyperthermia
• Hypoglycemia
• Shock

Unstable ventricular rhythms should be managed using appropriate resuscitation principles while toxin-specific treatment is initiated.

Sodium-Channel Blocker Cardiotoxicity

Sodium bicarbonate is the major therapy for significant poisoning characterized by sodium-channel blockade.

Clinical indications can include:

• Significant QRS widening
• Ventricular dysrhythmia attributable to sodium-channel blockade
• Hypotension associated with this mechanism

Therapy requires monitoring of:

• ECG response
• Blood pH
• Sodium
• Potassium

Excessive alkalemia and electrolyte abnormalities should be avoided.

Ventricular Tachycardia

Management depends on:

• Hemodynamic stability
• QRS morphology
• QT interval
• Suspected toxicant
• Underlying mechanism

An unstable patient with ventricular tachycardia requires immediate resuscitative rhythm management.

In toxicology, conventional antiarrhythmic selection must be made carefully because some drugs can worsen the underlying channel disturbance.

For example, adding another sodium-channel blocker to severe sodium-channel-blocker poisoning can aggravate conduction delay.

Torsades de Pointes

Torsades is a polymorphic ventricular tachycardia associated with prolonged ventricular repolarization.

Management includes:

• Stop QT-prolonging agents.
• Correct hypokalemia.
• Correct hypomagnesemia.
• Treat other contributing electrolyte abnormalities.
• Give IV magnesium when torsades occurs.
• Use electrical therapy if the patient is unstable or pulseless.

For recurrent pause-dependent torsades, increasing the heart rate with overdrive pacing may be considered in selected cases.

Additional QT-prolonging antiarrhythmics should generally be avoided.

Digoxin-Associated Dysrhythmias

The most important treatment for severe digoxin-associated cardiac toxicity is:

Digoxin immune Fab

This should be considered particularly when significant poisoning produces:

• Life-threatening ventricular dysrhythmias
• Severe bradydysrhythmias
• Clinically important hyperkalemia in acute toxicity
• Other evidence of severe digoxin poisoning

After Fab administration, routine total serum digoxin measurements can become misleading because assays detect both bound and unbound digoxin.

Electrolyte Correction

Correct clinically important abnormalities promptly.

Potassium

Both high and low potassium can cause or worsen dysrhythmias.

Magnesium

Deficiency increases susceptibility to torsades and other ventricular dysrhythmias.

Calcium

Marked abnormalities can alter cardiac conduction and repolarization.

The goal is to correct the physiologic abnormality while simultaneously treating its toxicologic cause.

Hypotension and Shock

Ventricular dysrhythmia may both cause and result from shock.

Assess for:

• Hypovolemia
• Vasodilation
• Myocardial depression
• Severe bradycardia/conduction block
• Persistent ventricular dysrhythmia

Management may require:

• Careful fluid resuscitation
• Vasopressors
• Poison-specific cardiovascular therapy
• Electrical therapy
• Advanced circulatory support in selected refractory poisonings

Routine large fluid volumes should not be given without considering myocardial function and the mechanism of shock.

Bradyarrhythmias in Poisoning

Although this topic focuses on ventricular dysrhythmias, severe poisoning may produce bradycardia or conduction block.

Important causes include:

• Beta-blockers
• Calcium channel blockers
• Digoxin
• Cholinergic agents
• Clonidine/imidazolines

Standard ACLS measures may be insufficient because the underlying toxic mechanism persists.

Management therefore emphasizes toxin-specific cardiovascular therapy, with pacing used when appropriate.

Decontamination

Do not induce vomiting.

Routine gastric lavage is generally not recommended.

Activated charcoal may be considered for a selected recent, serious, adsorbable ingestion when:

• The airway is adequately protected.
• Aspiration risk is acceptable.
• No major contraindication exists.
• Administration will not delay cardiovascular stabilization.

A patient with ventricular dysrhythmia, seizures, or altered consciousness should be stabilized before gastrointestinal decontamination is considered.

Monitoring and Disposition

A new clinically significant ventricular dysrhythmia associated with poisoning generally requires a high-acuity monitored setting.

Monitor:

• Continuous ECG
• Blood pressure
• Oxygenation
• Ventilation
• Mental status
• Temperature
• Electrolytes
• Acid-base status

Serial ECGs and toxicant-specific laboratory testing may be necessary.

Patients with severe cardiotoxic poisoning may require intensive care.

Important Modernization of the Older Source

Several elements of the source reflect older toxicology practice.

Current management generally avoids:

• Routine gastric lavage
• Routine treatment based solely on one fixed QRS cutoff
• Automatic use of lidocaine for every ventricular ectopic rhythm
• Routine phenytoin/fosphenytoin as therapy for toxicologic ventricular dysrhythmias
• Bretylium, which has essentially disappeared from modern routine practice
• Routine Trendelenburg positioning for hypotension
• Large empiric fluid administration without assessment of the shock mechanism

Modern treatment emphasizes mechanism-directed therapy, ECG interpretation, electrolyte correction, appropriate electrical therapy, and toxin-specific antidotes.

Key Points

• Toxicologic ventricular dysrhythmias can result from ion-channel blockade, myocardial ischemia, hypoxia, electrolyte abnormalities, or direct myocardial toxicity.
• Sodium-channel blockade typically causes progressive QRS widening and may lead to hypotension, seizures, and ventricular dysrhythmias.
• Important sodium-channel-blocking poisons include TCAs, certain antihistamines, class I antiarrhythmics, carbamazepine, and cocaine.
• Sodium bicarbonate is central to treatment of clinically important toxicologic sodium-channel blockade.
• QT prolongation increases susceptibility to torsades de pointes, particularly with hypokalemia or hypomagnesemia.
• Torsades is treated with IV magnesium and correction of contributing factors, with electrical therapy for instability.
• Digoxin can produce almost any dysrhythmia; bidirectional ventricular tachycardia is an important clue.
• Severe digoxin-associated dysrhythmias are treated with digoxin immune Fab.
• Chloroquine/hydroxychloroquine poisoning can cause rapid cardiovascular collapse, QRS/QT abnormalities, ventricular dysrhythmias, and marked hypokalemia.
• Stimulants may cause dysrhythmias through catecholamine excess, ischemia, hyperthermia, and acidosis.
• Correct hypoxia, acid-base abnormalities, potassium, magnesium, and calcium disturbances when clinically important.
• Do not assume that a standard antiarrhythmic is safe merely because the rhythm resembles a conventional cardiac dysrhythmia; the toxicologic mechanism matters.
• Unstable ventricular tachycardia or ventricular fibrillation requires immediate resuscitative electrical management while the underlying poisoning is treated.
• Significant poison-induced ventricular dysrhythmias generally require continuous cardiac monitoring and high-acuity care.